Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

23/09/2020 STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline 28/11/2019 Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose 26/07/2017 Guidance to develop individual dose recommendations for patients on chronic hemodialysis 17/03/2015 Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement 27/06/2013 Guidelines for field surveys of the quality of medicines: a proposal 20/06/2013 Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine 20/06/2013 Guidelines for submitting adverse event reports for publication

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More